Variant ID: 8-108503702-G-T


This variant was identified in 1 publication


Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.

Plos One
I Makhoul, VK Todorova, ER Siegel, SW Erickson, I Dhakal, VR Raj, JY Lee, MS Orloff, RJ Griffin, RS Henry-Tillman, S Klimberg, LF Hutchins, SA Kadlubar
Publication Date: 2017

Variant appearance in text: rs13272688
PubMed Link: 28045923
PubMed Central Link
Variant Present in the following documents:
  • pone.0168550.s011.xlsx
  • pone.0168550.s006.xlsx
  • pone.0168550.s007.xlsx
  • pone.0168550.s004.xlsx
  • pone.0168550.s009.xlsx
  • pone.0168550.s005.xlsx
  • pone.0168550.s003.xlsx
View BVdb publication page

Alternative transcript annotations:

Transcript cDNA Protein Consequence Exon Intron
ENST00000297450.3 c.297+5788C>A - intron_variant - 1/8
ENST00000517746.1 c.297+5788C>A - intron_variant - 1/8
ENST00000520033.1 c.-25+3089C>A - intron_variant - 1/1
NM_001146.5 c.297+5788C>A - intron_variant - 1/8
NM_001199859.3 c.297+5788C>A - intron_variant - 1/8